Department of Medicine Archive — Page 21 of 125
-
November 4, 2024
Tae Kon Kim receives V Foundation grant for MDS drug research
Kim and colleagues will study whether this protein hinders the ability of the immune system to fight MDS and whether it can be blocked to treat MDS. -
November 3, 2024
Greenlight study demonstrates effective early intervention in preventing childhood obesity
Researchers examined if childhood obesity could be prevented by leveraging a combination of health behavior counseling offered by pediatric primary care clinicians and modern digital health literacy tools. -
October 30, 2024
Genetic risk, sexual trauma associated with mental illness: study
Evaluating how genetic risk interacts with environmental risk factors such as sexual trauma is important for understanding how mental illness develops and identifying high-risk groups for early intervention. -
October 30, 2024
Michael Gibson votes with FDA panel to limit immunotherapy indication
The panel determined that allowing the wider indication would put patients at risk for adverse reactions from the two immunotherapies but without the added benefit in survival. -
October 25, 2024
Blockbuster obesity drugs also may slow kidney disease
The report supports previous clinical trials that found the GLP-1 receptor agonist drug semaglutide reduced kidney disease progression in patients with Type 2 diabetes. -
October 22, 2024
VUMC, Nigeria teaching hospital to study genetic risk of fibroids based on regional African ancestry
The research team will analyze existing genome-wide association study data and RNA sequencing to compare fibroid development patterns in Nigerian women and U.S. Black women, which could point to targeted therapies and management strategies for affected women. -
October 21, 2024
Anna Person honored for teaching by Infectious Diseases Society of America
Person, an award citation reads in part, “has been a champion for empathy and equity in caring for patients. ... She models for her learners how to compassionately care.”